Zuclotrip-Acuphase 50 mg Injection 1 ml belongs to a class of medications called antipsychotics used to treat schizophrenia (a mental illness) and other psychotic disorders. Additionally, Zuclotrip-Acuphase 50 mg Injection 1 ml may be used in the initial treatment of mania over the short term. Schizophrenia is a mental disorder that affects the ability of a person to feel, think and behave clearly.

Zuclotrip-Acuphase 50 mg Injection 1 ml contains Zuclopenthixol which works by inhibiting the dopamine (chemical messenger) receptors in the brain. Dopamine is involved in regulating mood, behaviour and emotions. Thereby, Zuclotrip-Acuphase 50 mg Injection 1 ml helps in controlling psychotic illness by preventing the overactivity of dopamine in the brain. Thus, it helps in improving feelings, disturbed thoughts and behaviour.

Zuclotrip-Acuphase 50 mg Injection 1 ml will be administered by a healthcare professional; do not self-administer. Some people may experience sleepiness, akathisia (inability to sit still or remain motionless), dry mouth, hyperkinesia (involuntary movements), hypokinesia (slow or diminished movements), constipation, muscle pain, tremor, or headache. Most of these side effects of Zuclotrip-Acuphase 50 mg Injection 1 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Zuclopenthixol or any other medicines, please tell your doctor. Zuclotrip-Acuphase 50 mg Injection 1 ml is not recommended for children. Zuclotrip-Acuphase 50 mg Injection 1 ml is not recommended during pregnancy unless clearly necessary because using it during the third trimester may cause adverse effects in the baby, such as breathing problems, muscle stiffness or weakness, shaking, etc. Zuclotrip-Acuphase 50 mg Injection 1 ml may be excreted in breast milk. Therefore, avoid taking Zuclotrip-Acuphase 50 mg Injection 1 ml if you are breastfeeding. Do not consume alcohol with Zuclotrip-Acuphase 50 mg Injection 1 ml as it may increase the sedative effects of alcohol. Drive only if you are alert, as Zuclotrip-Acuphase 50 mg Injection 1 ml may cause dizziness, double vision or drowsiness.

Zuclotrip-Acuphase 50 mg Injection 1 ml contains Zuclopenthixol used to treat schizophrenia (a mental illness) and other psychotic disorders. Additionally, Zuclotrip-Acuphase 50 mg Injection 1 ml may be used in the initial treatment of mania over the short term. Zuclotrip-Acuphase 50 mg Injection 1 ml inhibits the dopamine (chemical messenger) receptors in the brain. Dopamine is involved in regulating mood, behaviour and emotions. Thereby, Zuclotrip-Acuphase 50 mg Injection 1 ml helps in controlling psychotic illness by preventing the overactivity of dopamine in the brain. Thus, it helps in improving feelings, disturbed thoughts and behaviour. Also, Zuclotrip-Acuphase 50 mg Injection 1 ml produces a calming effect and controls hallucinations, aggression and delusions (false beliefs).

If you are allergic to Zuclopenthixol or any other medicines, please tell your doctor. If you have liver, kidney, heart or thyroid problems, inform your doctor before taking Zuclotrip-Acuphase 50 mg Injection 1 ml. Zuclotrip-Acuphase 50 mg Injection 1 ml is not recommended for children. Zuclotrip-Acuphase 50 mg Injection 1 ml is not recommended during pregnancy unless clearly necessary as using it during third trimester may cause adverse effects in the baby such as breathing problems, muscle stiffness or weakness, shaking, etc. Zuclotrip-Acuphase 50 mg Injection 1 ml may be excreted in breast milk. Therefore, avoid taking Zuclotrip-Acuphase 50 mg Injection 1 ml if you are breastfeeding. Inform your surgeon, anaesthetist or dentist before any surgery that you are on treatment with Zuclotrip-Acuphase 50 mg Injection 1 ml. Do not consume alcohol with Zuclotrip-Acuphase 50 mg Injection 1 ml as it may increase sedative effects of alcohol. Drive only if you are alert as Zuclotrip-Acuphase 50 mg Injection 1 ml may cause dizziness, double vision or drowsiness.